EMG
ANAC

Ellington Management Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Ellington Management Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-25,000
Closed -$500K – 845
2014
Q1 		$500K Buy
+25,000
New +$485K 0.15% 219

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Ellington Management Group's ANAC Position: Q2 2014 in Review

Ellington Management Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2014, closing a stake of 25,000 shares — an estimated $500K sold.

Ellington Management Group first reported a position in ANAC in Q1 2014 and held it in 1 quarter. The position peaked at $500K in Q1 2014. 107 funds tracked by Wall St. Rank hold ANAC as of Q2 2014.

  • Ellington Management Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2014 after selling out during the quarter.
  • Ellington Management Group sold 25,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2014, an estimated $500K.
  • Ellington Management Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 1 quarter.
  • Ellington Management Group's ANACOR PHARMACEUTICALS INC COM position peaked at $500K in Q1 2014.
  • 107 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2014.

Based on Ellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.